A global view on the role of monocytes and platelets in atherogenesis

Thrombosis Research

Volumn 85, Issue 1, 1997, Pages 1-22

  Østerud, Bjarne ^a  

^a UNIVERSITY OF TROMSØ   (Norway)

Author keywords

atherogenesis; blood cells; estrogen; lipids; monocytes; platelets; transcription factors

Indexed keywords

ATHEROSCLEROSIS; HUMAN; MONOCYTE; PRIORITY JOURNAL; REVIEW; THROMBOCYTE;

EID: 0031037059     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(96)00205-8     Document Type: Article

References (116)

1. WITZTUM, J.L. and STEINBERG, D. Role of oxidized low density lipoprotein in atherogenesis. J Clin Invest 88, 1785-1792, 1991.
2. STEINBERG, D. Modified forms of low-density lipoprotein and atherosclerosis. J Intern Med 233, 227-232, 1993.
3. HOLVOET, P. and COLLEN, D. Oxidized lipoproteins in atherosclerosis and thrombosis. FASEB J 8, 1279-1284, 1994.
4. MACKNESS, M.I. and DURRINGTON, P.N. HDL, its enzymes and its potential to influence lipid peroxidation. Atherosclerosis 115, 243-253, 1995.
5. KARPE, F. and HAMSTEN, A. Postprandial lipoprotein metabolism and atherosclerosis. Curr Opin Lipidol 6, 123-129, 1995.
6. POMERANTZ, K.B., NICHOLSON, A.C. and HAJJAR, D.P. Signal transduction in atherosclerosis: Second messengers and regulation of cellular cholesterol trafficking. Adv Exp Med Biol 369, 49-64, 1995.
7. NIELSEN, L.B. Transfer of low density lipoprotein into the arterial wall and risk of atherosclerosis. Atherosclerosis 123, 1-15, 1996.
8. BERLINER, J.A. and HEINECKE, J.W. The role of oxidized lipoproteins in atherogenesis. Free Radic Biol Med 20, 707-727, 1996.
9. ØSTERUD, B. and ESKELAND, T. The mandatory role of complement in the endotoxin-induced synthesis of tissue thromboplastin in blood monocytes. FEBS Lett 149, 75-79, 1982.
10. ØSTERUD, B., OLSEN, J.O. and WILSGÅRD, L. The role of arachidonic acid release and lipoxygenase pathway in lipopolysaccharid-induced thromboplastin activity in monocytes. Blood Coagul Fibrinolysis 1, 41-46, 1990.
11. ØSTERUD, B. The high responder phenomenon: Enhancement of LPS induced tissue factor activity in monocytes by platelets and granulocytes. Platelets 6, 119-125, 1995.
12. STRIETER, R.M., KUNKEL, S.L. and BONE, R.C. Role of tumor necrosis factor-alpha in disease states and inflammation. Crit Care Med 21, 447-463, 1993.
13. OKANO, M. and YOSHIDA, Y. Endothelial cell morphometry of atherosclerotic lesions and flow profiles at aortic bifurcations in cholesterol fed rabbits. J Biomech Eng 114, 301-308, 1992.
14. MOORE, S. Pathogenesis of atherosclerosis. Metabolism 34, 13-16, 1985.
15. PACKHAM, M.A. and MUSTARD, J.F. The role of platelets in the development and complications of atherosclerosis. Semin Hematol 23, 8-26, 1986.
16. MYERS, S.I., RUSSEL, D.H., PARKS, L. and REED, M.K. Triphasic response of prostacyclin production in rabbit thoracic aorta in early atherosclerosis. Prostaglandins Leukot Essent Fatty Acids 44, 31-36, 1991.
17. TANNER, F.C., BOULANGER, C.M. and LUSCHER, T.F. Endothelium-derived nitric oxide, endothelin, and platelet vessel wall interaction: Alteration in hypercholesterolemia and atherosclerosis. Semin Thromb Hemost 19, 167-175, 1993.
18. CANDIPAN, R.C., WANG, B.Y., BUITRAGO, R., TSAO, P.S., COOKE, J.P. Regression or progression. Dependency on vascular nitric oxide. Arterioscler Thromb Vasc Biol 16, 44-50, 1996.
19. CERILLI, J., BRASILE, L. and KARMODY, A. Role of the vascular endothelial cell antigen system in the etiology of atherosclerosis. Ann Surg 202, 329-334, 1985.
20. MALINAUSKAS, R.A., HERRMANN, R.A. and TRUSKEY, G.A. The distribution of intimal white blood cells in the normal rabbit aorta. Atherosclerosis 115, 147-163, 1995.
21. CHESTERMAN, C.N. and BERNDT, M.C. Platelet and vessel wall interaction and the genesis of atherosclerosis. Clin Haematol 15, 323-353, 1986.
22. SCHWARTZ, C.J., VALENTE, A.J., SPRAGUE, E.A., KELLEY, J.L., SUENRAM, C.A., GRAVES, D.T., ROZEK, M.M. EDWARDS, E.H. and DELGADO, R. Monocyte-macrophage participation in atherogenesis: Inflammatory components of pathogenesis. Semin Thromb Hemost 12, 79-86, 1986.
23. SCHWARTZ, C.J., VALENTE, A.J., SPRAGUE, E.A., KELLEY, J.L. and NEREM, R.M. The pathogenesis of atherosclerosis: an overview. Clin Cardiol 14, 11-16, 1991.
24. KLING, D., HOLZSCHUH, T. and BETZ, E. Recruitment and dynamics of leukocytes in the formation of arterial intimal thickening - A comparative study with normo-and hypercholesterolemic rabbits. Atherosclerosis 101, 79-96, 1993.
25. WEINBAUM, S. and CHIEN, S. Lipid transport aspects of atherogenesis. J Biomech Eng 115, 602-610, 1993.
26. JIALAL, L. and DEVARAJ, S. The role of oxidized low density lipoprotein in atherogenesis. J Nutr 126, 1053S-1057S, 1996.
27. JORIS, I., ZAND, T., NUNNARI, J.J., KROLIKOWSKI, F.J. and MAJNO, G. Studies on the pathogenesis of atherosclerosis. I. Adhesion and emigration of mononuclear cells in the aorta of hypercholesterolemic rats. Am J Pathol 113, 341-358, 1983.
28. BEVILACQUA, M.P. and NELSON, R.M. Selecting. J Clin Invest 91, 379-387, 1993.
29. BEVILACQUA, M.P., NELSON, R.M., MANNORI, G. and CECCONI, O. Endothelial-leukocyte adhesion molecules in human disease. Annu Rev Med 45, 361-378, 1994.
30. LARSEN, E., CELI, A., GILBERT, G.E., FURIE, B.C., ERBAN, J.K. BONFANTI, R., WAGNER, D.D. and FURIE, B. Padgem protein: A receptor that mediates the interaction of activated platelets with neutrophils and moocytes. Cell 59, 305-312, 1989.
31. McEVER, R.P. Role of selectins in leukocyte adhesion to platelets and endothelium. Ann NY Acad Sci 714, 185-189, 1994.
32. McEVER, R.P. Regulation of function and expression of P-selectin. Agents Actions Suppl 47, 117-119, 1995.
33. MOORE, K.L., PATEL, K.D., BRUEHL, R.E., LI, F., JOHNSON, D.A., LICHEN STEIN, H.S., CUMMINGS, R.D., BAINTON, D.F. and McEVER, R.P. P-Selectin glycoprotein ligand-1 mediates rolling of human neutrophils on P-selectin. J Cell Biol 128, 661-671, 1995.
34. FRENETTE, P.S., JOHNSON, R.C., HYNES, R.O. and WAGNER, D.D. Platelets roll on stimulated endothelium in vivo: An interaction mediated by endothelial P-selectin. Proc Natl Acad Sci USA 92, 7450-7454, 1995.
35. CELI, A., PELLEGRINI, G., LORENZET, R., DE BLASI, A., READY, N., FURIE, B.C. and FURIE, B. P-Selection induces the expression of tissue factor on monocytes. Proc Natl Acad Sci USA 31, 8767-8771, 1994.
36. ENGSTAD, C.S., LIA, K., REKDAL, Ø., OLSEN, J.O. and ØSTERUD, B. A novel biological effect of platelet factor 4 (PF4): Enhancement of LPS-induced tissue factor activity in monocytes. J Leukoc Biol 58, 575-581, 1995.
37. WEYRICH, A.S., ELSTAD, M.R., McEVER, R.P., McINTYRE, T.M., MOORE, K.L., MORRISSEY, J.H., PRESCOTT, S.M. and ZIMMERMAN, G.A. Activated platelets signal chemokine synthesis by human monocytes. J Clin Invest 97, 1525-1534, 1996.
38. RINDER, H.M., BONAN, J.L., RINDER, C.S., AULT, K.A. and SMITH, B.R. Dynamics of leukocyte-platelet adhesion in whole blood. Blood 78, 1730-1737, 1991.
39. NABEL, E.G. Biology of the impaired endothelium. Am J Cardiol 68, 6-8, 1991.
40. JANG, I.K., LASSILA, R. and FUSTER, V. Atherogenesis and inflammation. Eur Heart J 14, 2-6, 1993.
41. VAN-ZANTEN, G.H., DE-GRAAF, S., SLOOTWEG, P.J., HEIJNEN, H.F., CONNOLLY, T.M., DE-GROOT, P.G. and SIXMA, J.J. Increased platelet deposition on atherosclerotic coronary arteries. J Clin Invest 93, 615-632, 1994.
42. HAWIGER, J. Mechanisms involved in platelet vessel wall interaction. Thromb Haemost 74, 369-372, 1995.
43. WAGNER, D.D. P-selectin knockout: A mouse model for various human diseases. Ciba Found Symp 189, 10-16, 77-78, 1995.
44. HALVORSEN, H., OLSEN, J.O. and ØSTERUD, B. Granulocytes enhance LPS-induced tissue factor activity in monocytes via an interaction with platelets. J Leukoc Biol 54, 275-282, 1993.
45. QUINN, M.T., PARTHASARATHY, S. and STEINBERG, D. Lysophosphatidylcholine: A chemotactic factor for human monocytes and its potential role in atherogenesis. Proc Natl Acad Sci USA 85, 2805-2809, 1988.
46. NAKANO, T., RAINES, E.W., ABRAHAM, J.A., KLAGSBRUN, M. and ROSS, R. Lysophosphatidylcholine upregulates the level of heparin-binding epidermal growth factor-like growth factor mRNA in human monocytes. Proc Natl Acad Sci USA 91, 1069-1073, 1994.
47. 2+ influx, enhanced DNA synthesis and cytotoxicity in cultured vascular smooth muscle cells. Atherosclerosis 112, 69-76, 1995.
48. MUROHARA, T., SCALIA, R. and LEFER, A.M. Lysophosphatidylcholine promotes P-selectin expression in platelets and endothelial cells. Possible involvement of protein kinase C activation and its inhibition by nitric oxide donors. Circ Res 78, 780-790, 1996.
49. HJELMS, E., NORDESTGAARD, B.G., STENDER, S. and KJELDSEN, K. A surgical model to study in vivo efflux of cholesterol from porcine aorta. Evidence for cholesteryl ester transfer through the aortic wall. Atherosclerosis 77, 239-249, 1989.
50. SCHWENKE, D.C. and ST. CLAIR, R.W. Influx, efflux, and accumulation of LDL in normal arterial areas and atherosclerotic lesions of white Carneau pigeons with naturally occurring and cholesterol-aggravated aortic atherosclerosis. Arterioscler Thromb 13, 1368-1381, 1993.
51. PENN, M.S., SAIDEL, G.M. and CHISOLM, G.M. Relative significance of endothelium and internal elastic lamina in regulating the entry of macromolecules into arteries in vivo. Circ Res 74, 74-82, 1994.
52. ARBUSTINI, E., GRASSO, M., DIEGOLI, M., PUCCI, A., BRAMERIO, M., ARDISSINO, D., ANGOLI, L., DeSERVI, S., BRAMUCCI, E., MUSSINI, A., MINZIONI, G., VIGANO, M. and SPECCHIA, G. Coronary atherosclerotic plaques with and without thrombus in ischemie heart syndromes: A morphologic, immunohistochemical, and biochemical study. Am J Cardiol 68, 36B-50B, 1991.
53. SMITH, C., MITCHINSON, M.J., ARUOMA, OL. and HALLIWELL, B. Stimulation of lipid peroxidation and hydroxyl-radical generation by the contents of human atherosclerotic lesions. Biochem J 286, 901-905, 1992.
54. ESTERBAUER, H., DIEBER-ROTHENEDER, M., STRIEGL, G. and WAEG, G. Role of vitamin E in preventing the oxidation of low-density lipoprotein. Am J Clin Nutr 53, 314-321, 1991.
55. ESTERBAUER, H., DIEBER-ROTHENEDER, M., WAEG, G., STRIEGL, G. and JURGENS, G. Biochemical, structural, and functional properties of oxidized low-density lipoprotein. Chem Res Toxicol 3, 77-92, 1990.
56. MUROPHARA, T., KUGIYAMA, K., OHGUSHI, M., SUGIYAMA, S., OHTA, Y. and YASUE, H. LPC in oxidized LDL elicits vasocontraction and inhibits endothelium-dependent relaxation. Am J Physiol 267, 2441-2449, 1994.
57. LIU, S.Y., LU, X., CHOY, S., DEMBINSKI, T.C., HATCH, G.M., MYMIN, D., SHEN, X., ANGEL, A., CHOY, P.C. and MAN, R.Y. Alteration of lysophosphatidylcholine content in low density lipoprotein after oxidative modification: Relationship to endothelium dependent relaxation. Cardiovasc Res 28, 1476-1481, 1994.
58. KUME, N., CYBULSKY, M.I. and GIMBRONE, M.A., Jr. Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells. J Clin Invest 90, 1138-1144, 1992.
59. HABERLAND, M.E., FONG, D. and CHENG, L. Malondialdehyde-altered protein occurs in atheroma of Watanabe heritable hyperlipidemic rabbits. Science 241, 215-218, 1988.
60. YLA-HERTTUALA, S., PALINSKI, W., ROSENFELD, M.E., PARTHASARATHY, S., CAREW, T.W., BUTLER, S., WITZTUM, J.L. and STEINBERG, D. Evidence for the presence of oxidatively modified low density lipoprotein low density lipoprotein in atherosclerotic lesions of rabbit and man. J Clin Invest 84, 1086-1095, 1989.
61. YLA-HERTTUALA, S., PALINSKI, W., BUTLER, S.W., PICARD, S., STEINBERG, D. and WITZTUM, J.L. Rabbit and human atherosclerotic lesions contain IgG that recognizes epitopes of oxidized LDL. Arterioscler Thromb 14, 32-40, 1994.
62. BHAKDI, S., DORWEILER, B., KIRCHMANN, R., TORZEWSKI, J., WEISE, E., TRANUM-JENSEN, J., WALEV, I. and WIELAND, E. On the pathogenesis of atherosclerosis: Enzymatic transformation of human low density lipoprotein to an atherogenic moiety. J Exp Med 182, 1959-1971, 1995.
63. ØSTERUD, B., LINDAHL, U. and SELJELID, R. Macrophages produce blood coagulation factors. FEBS Lett 120, 41-43, 1980.
64. ØSTERUD, B., BØGWALD, J., LINDAHL, U. and SELJELID, R. Production of blood coagulation factor V and tissue thromboplastin by macrophages in vitro. FEBS Lett 127, 154-160, 1981.
65. McGEE, M.P., DEVLIN, R., SALUTA, G. and KOREN, H. Tissue factor and factor VII messenger RNAs in human alveolar macrophages: Effects of breathing ozone. Blood 75, 122-127, 1990.
66. ROSS, R. The pathogenesis of atherosclerosis: A perspective for the 1990s. Nature 362, 801-809, 1993.
67. ROSS, R. Cell biology of atherosclerosis. Physiology 57, 791-804, 1995.
68. DAVIES, M. J. The contribution of thrombosis to the clinical expression of coronary atherosclerosis. Thromb Res 82, 1-32, 1996.
69. GALLO, R., FALLON, J.T., TOSCHI, V., GERTZ, S.D., PADUREAN, A., NEMERSON, Y., CHESEBRO, J.H., FUSTER, V. and BADIMON, J.J. Circulation 92, 1-354, 1995.
70. STEMME. S. and HANSSON, G.K. Immune mechanisms in atherosclerosis. Coron-Artery-Dis. 5, 216-222, 1994.
71. HØGMO, P. and ØSTERUD, B. In vitro effects of HWA 138 and methylprednisolone on lipopolysaccharide (LPS)-induced activation products from human blood cells in whole blood. FEBS Abstract book; 1995:333.
72. TERNISIEN, C., RAMANI, M., OLLIVIER, V., KHECHAI, F., VU-T., HAKIM, J. and De-PROST, D. Endotoxin-induced tissue factor in human monocytes is dependent upon protein kinase C activation. Thromb Haemost 70, 800-806, 1993.
73. ØSTERUD, B. Monocytes and hypercoagulable states. In: Hypercoagulable States: Biological Aspects and Clinical Management. J. Segahatchian, M.M. Samama and S.P. Hecker (eds)., pp. 37-46, CRC Press, Boca Raton, FL (1996).
74. RAJAVASHISTH, T.B., YAMADA, H. and MISHRA, N.K. Transcriptional activation of the macrophage-colony stimulating factor gene by minimally modified LDL. Involvement of nuclear factor-kappa B. Arterioscler Thromb Vasc Biol 15, 1591-1598, 1995.
75. ANDALIBI, A., LIAO, F., IMES, S., FOGELMAN, A.M. and LUSIS, A.J. Oxidized lipoproteins influence gene expression by causing oxidative stress and activating the transcription factor NF-kappa B. Biochem Soc Trans 21, 651-655, 1993.
76. LIAO, F., ANDALIBI, A., QIAO, J.H., ALLAYEE, H., FOGELMAN, A.M. and LUSIS, A.J. Genetic evidence for a common pathway mediating oxidative stress, inflammatory gene induction, and aortic fatty streak formation in mice. J Clin Invest 94, 877-884, 1994.
77. REGISTER, T.C., BORA, T.A. and ADAMS, M.R. Estrogen inhibits activation of arterial NF-κB transcription factor in early diet-induced atherosclerosis. Circulation 92, I-628, 1995.
78. YLA-HERTTUALA, S., ROSENFELD, M.E., PARTHASARATHY, S., GLASS, C.K., SIGAL, E., WITZTUM, J.L. and STEINBERG, D. Colocalization of 15-lipoxygenase mRNA and protein with epitopes of oxidized low density lipoprotein in macrophagerich areas of atherosclerotic lesions. Proc Natl Acad Sci USA 87, 6959-6963, 1990.
79. TAKAHASHI, Y., GLASGOW, W.C., SUZUKI, H., TAKETANI, Y., YAMAMOTO, S., ANTON, M., KUHN, H. and BRASH, A.R. Investigation of the oxygenation of phospholipids by the porcine leukocyte and human platelet arachidonate 12-lipoxygenases. Eur J Biochem 218, 165-171, 1993.
80. MATHUR, S.N., ALBRIGHT, E. and FIELD, F.J. Regulation of 12-hydroxyeicosatetraenoic acid synthesis by acetyl-LDL in mouse peritoneal macrophages. Biochim Biophys Acta 1001, 50-59, 1989.
81. WILKINS, G.M. and LEAKE, D.S. The effect of inhibitors of free radical generating-enzymes on low-density lipoprotein oxidation by macrophages. Biochim Biophys Acta 1211, 69-78, 1994.
82. ØSTERUD, B. Platelet activating factor enhancement of lipopolysaccharide-induced tissue factor activity in monocytes: Requirement of platelets and granulocytes. J Leukoc Biol 51, 462-465, 1992.
83. VAPAATALO, H. Free radicals and anti-inflammatory drugs. Med Biol 64, 1-7, 1986.
84. ASAI, K., FUNAKI, C., HAYASHI, T., HAMADA, K., NAITO, M., KUZUYA, M., YOSHIDA, F., YOSHIMINE, N. and KUZUYA, F. Arterioscler Thromb 13, 892-899, 1993.
85. BAILEY, J.M. and BUTLER, J. Anti-inflammatory drugs in experimental atherosclerosis. I. Relative potencies for inhibiting plaque formation. Atherosclerosis 17, 515-522, 1973.
86. NAITO, M., YASUE, M., ASAI, K., YAMADA, K., HAYASHI, T., KUZUYA, M., FUNAKI, C., YOSHIMINE, N. and KUZUYA, F. Effects of dexamethasone on experimental atherosclerosis in cholesterol-fed rabbits. J Nutr Sci Vitaminol Tokyo 38, 255-264, 1992.
87. MAKHEJA, A.N., BLOOM, S., MUESING, R., SIMON, T. and BAILEY, J.M. Anti-inflammatory drugs in experimental atherosclerosis. 7. Spontaneous atherosclerosis in WHHL rabbits and inhibition by cortisone acetate. Atherosclerosis 76, 155-161, 1989.
88. LEIBOVICH, S. J. and ROSS, R. The role of the macrophage in wound repair. A study with hydrocortisone and antimacrophage serum. Am J Pathol 78, 71-100, 1975.
89. SPENCE, J.D. Advances in atherosclerosis. Baillieres Clin Neurol 4, 191-205, 1995.
90. GILLIGAN, D.M., BADAR, D.M., PANZA, J.A., QUYYUMI, A.A., CANNON, R.O. III. Acute vascular effects of estrogen in postmenopausal women. Circulation 90, 786-791, 1994.
91. POLDERMAN, K.H., STEHOUWER, C.D., VANKAMP, G.J., DEKKER, G.A., VERHEUGT, F.W. and GOOREN, L.J. Influence of sex hormones on plasma endothelin levels. Ann Intern Med 118, 429-432, 1993.
92. HANSEN, J.-B., OLSEN, J.O., WILSGÅRD, L. and ØSTERUD, B. Effect of dietary intervention with highly purified fish oils on serum lipids, platelet function, coagulation and fibrinolysis. Thromb haemost 62, 332, 1989.
93. BALTESKARD, L., BROX, J.H. and ØSTERUD, B. Thromboxane production in the blood of women increases after menopause whereas tumor necrosis factor is reduced in women compared with men. Atherosclerosis 102, 91-98, 1993.
94. OMSJØ, I., IAN, P. and ØSTERUD, B. Thromboplastin activity in blood monocytes from oral contraceptive users. Gynecol Obstet Invest 22, 194-197, 1986.
95. AUNE, B., ØIAN, P., OMSJØ, I. and ØSTERUD, B. Hormone replacement therapy reduces the reactivity of monocytes and platelets in whole blood - A beneficial effect on atherogenesis and thrombus formation? Am J Obstet Gynecol 173, 1816-1820, 1995.
96. HENKEL, T., MACHLEIDT, T., ALKALAY, I., KRONKE, M., BEN-NERIAH, Y. and BAEUERLE, P.A. Rapid proteolysis of I kappa B-alpha is necessary for activation of transcription factor NF-kappaB. Nature 365, 182-185, 1993.
97. BAEUERLE, P.A. and HENKEL, T. Function and activation of NFκB in the immune system. Annu Rev Immunol 12, 11141-11178, 1994.
98. BRUCK, B., HEINLE, H., GUGELER, N., HANKE, H., HANKE, S., BREHME, U., GUGEL, N., DRYSCH, K., KAHLE, P.F., HAASIS, R. and SCHMAHL, F.W. The effects of estrogen and progesterone on oxidized LDL in vivo in an experimental model. Circulation 92(Suppl. 1), I-626, 1995.
99. HANKE, H., HANKE, S., FINKING, G., MUHIC-LOHRER, A., MACK, A.O., KAMENZ, J., SCHMAHL, F.W. HAASIS, R. and HOMBACH, V. Different effects of estrogen and progesterone on experimental atherosclerosis in female vs. male rabbits. Circulation 92(Suppl. 1), I-627, 1995.
100. NAGATA, K., TSUJI, T., TODOROKI, N., KATAGIRI, Y., TANOUE, K., YAMAZAKI, H., HANAI, N. and IRIMURA, T. Activated platelets induce superoxide anion release by monocytes and neutrophils through P-selectin (CD62). J Immunol 151, 3267-3273, 1993.
101. PALABRICA, T., LOBB, R., FURIE, B.C., ARONOVITZ, M., BENJAMIN, C., HSU, Y.M., SAJER, S.A. and FURIE, B. Leukocyte accumulation promoting fibrin deposition is mediated in vivo by P-selectin on adherent platelets. Nature 359, 848-851, 1992.
102. WEISS, E.J., BRAY, P.F., TAYBACK, M., SCHULMAN, S.P., KICKLER, T.S., BECKER, L.C., WEISS, J.L., GERSTENBLITH, G. and GOLDSCHMIDT-CLERMONT, P.J. A polymorphism of a platelet glycoprotein receptor as an inherited risk factor for coronary thrombosis. N Engl J Med 334, 1090-1094, 1996.
103. SUH, T.T., HOLMBACK, K., JENSEN, N.J., DAUGHERTY, C.C., SMALL, K., SIMON, D.I., POTTER, S. and DEGEN, J.L. Resolution of spontaneous bleeding events but failure of pregnancy in fibrinogen-deficient mice. Genes Dev 9, 2020-2033, 1995.
104. LANE, A., GRAHAM, L., COOK, M., CHANTRY, D., GREEN, F., NIGON, F. and HUMPHRIES, SE Cytokine production by cholesterol-loaded human peripheral monocyte-macrophages: The effect on fibrinogen mRNA levels in a hepatoma cell-line (HepG2). Biochim Biophys Acta 1097, 161-165, 1991.
105. BANK, H.O., DYERBERG, J. and NIELSEN, A.B. Plasma lipid and lipoprotein pattern in greenlandic west-coast eskimos. Lancet 1, 1143-1145, 1971.
106. HISER, E. The mediterranean diet and cardiovascular disease. J Cardpulm Rehabil 15, 179-182, 1995.
107. DYERBERG, J. and BANG, H.O. Lipid metabolism, atherogenesis, and haemostasis in eskimos: The role of the prostaglandin-3 family. Haemostasis 8, 227-233, 1979.
108. BLOK, W.L. KATAN, M.B. and van der MEER, J.W. Modulation of inflammation and cytokine production by dietary (n-3) fatty acids. J Nutr 126, 1515-1533, 1996.
109. HANSEN, J.B., OLSEN, J.O., WILSGÅRD, L. and ØSTERUD, B. Effects of dietary supplementation with cod liver oil on monocyte thromboplastin synthesis, coagulation and fibrinolysis. J Intern Med Suppl 225, 133-139, 1989.
110. HANSEN, J.B., OLSEN, J.O., WILSGÅRD, L. and ØSTERUD, B. Effect of dietary intervention with highly purified fish oils on serum lipids, platelet function, coagulation and fibrinolysis. Thromb Haemost 62, 332, 1989.
111. ØSTERUD, B., ELVEVOLL, E., BARSTAD, H., BROX, J., HALVORSEN, H., LIA, K., OLSEN, J.O., OLSEN, R.L., SISSENER, C. and REKDAL, Ø. Effect of marine oils supplementation on coagulation and cellular activation in whole blood. Lipids 30, 1111-1118, 1995.
112. TREMOLI, E., ELIGINI, S., COLLI, S., MADERNA, P., RISE, P., PAZZUCCONI, F., MARANGONI, F., SIRTORI, C.R. and GALLI, G. N-3 fatty acid ethyl ester administration to healthy subjects and to hypertriglyceridemic patients reduces tissue factor activity in adherent monocytes. Arterioscler Thromb 14, 1600-1608, 1994.
113. RENAUD, S. and DE-LORGERIL, M. Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet 359, 1523-1526, 1992.
114. OLSEN, H. and ØSTERUD, B. Effects of ethanol on human blood fibrinolysis and coagulation. Alcohol Suppl. 1, 591-604, 1987.
115. KAWAKAMI, M., SWITZER, B.R., HERZOG, S.R. and MEYER, A.A. Immune suppression after acute ethanol ingestion and thermal injury. J Surg Res 51, 210-215, 1991.
116. SOLBERG, S., ØSTERUD, B., LARSEN, T. and SØRLIE, D. Lack of ability to synthesize tissue factor by endothelial cells in intact human saphenous veins. Blood Coagul Fibrinolysis 1, 595-600, 1990.